Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.8.0.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - 9 months ended Sep. 30, 2017 - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [ Member]
Total
Balance at beginning at Dec. 31, 2016 $ 18 $ 85,234 $ (28,262) $ 56,990
Balance at beginning (in shares) at Dec. 31, 2016 17,878,725      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation - stock options   592   592
Cashless exercise of warrants $ 1 (1)    
Cashless exercise of warrants (in shares) 1,173,296      
Exercise of warrants to purchase common stock   15   15
Exercise of warrants to purchase common stock (in shares) 2,500      
Exercise of options to purchase common stock   1,068   $ 1,068
Exercise of options to purchase common stock (in shares) 283,310     283,310
Common stock issued under Officers and Directors Purchase Plan   1   $ 1
Common stock issued under Officers and Directors Purchase Plan (in shares) 182      
Common stock issued for cash in February 2017 from Johnson Controls, net of $167 transaction cost $ 1 10,471   10,472
Common stock issued for cash in February 2017 from Johnson Controls, net of $167 transaction cost (in shares) 939,005      
Common stock issued for purchase of Ebonex IPR Limited   2,149   2,149
Common stock issued for purchase of Ebonex IPR Limited (in shares) 123,776      
Net loss     (19,549) (19,549)
Balance at end at Sep. 30, 2017 $ 20 $ 99,529 $ (47,811) $ 51,738
Balance at end (in shares) at Sep. 30, 2017 20,400,794